- Home
- BWEN vs NRXP Comparison
BWEN vs NRXP Comparison
Compare BWEN & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWEN
- NRXP
- Stock Information
- Founded
- BWEN N/A
- NRXP 2015
- Country
- BWEN United States
- NRXP United States
- Employees
- BWEN N/A
- NRXP N/A
- Industry
- BWEN Industrial Machinery/Components
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- BWEN Industrials
- NRXP Health Care
- Exchange
- BWEN Nasdaq
- NRXP Nasdaq
- Market Cap
- BWEN 32.1M
- NRXP 34.7M
- IPO Year
- BWEN N/A
- NRXP N/A
- Fundamental
- Price
- BWEN $1.68
- NRXP $1.93
- Analyst Decision
- BWEN Strong Buy
- NRXP Strong Buy
- Analyst Count
- BWEN 3
- NRXP 4
- Target Price
- BWEN $4.50
- NRXP $28.25
- AVG Volume (30 Days)
- BWEN 94.0K
- NRXP 148.0K
- Earning Date
- BWEN 05-13-2025
- NRXP 05-13-2025
- Dividend Yield
- BWEN N/A
- NRXP N/A
- EPS Growth
- BWEN N/A
- NRXP N/A
- EPS
- BWEN 0.05
- NRXP N/A
- Revenue
- BWEN $143,136,000.00
- NRXP N/A
- Revenue This Year
- BWEN $8.78
- NRXP N/A
- Revenue Next Year
- BWEN $10.05
- NRXP N/A
- P/E Ratio
- BWEN $33.60
- NRXP N/A
- Revenue Growth
- BWEN N/A
- NRXP N/A
- 52 Week Low
- BWEN $1.41
- NRXP $1.10
- 52 Week High
- BWEN $4.65
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- BWEN 63.32
- NRXP 45.32
- Support Level
- BWEN $1.51
- NRXP $1.63
- Resistance Level
- BWEN $1.68
- NRXP $2.14
- Average True Range (ATR)
- BWEN 0.08
- NRXP 0.17
- MACD
- BWEN 0.02
- NRXP 0.03
- Stochastic Oscillator
- BWEN 96.15
- NRXP 62.50
About BWEN Broadwind Inc.
Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.